Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
1624.40
Change Change %
-17.50 -1.07%

Updated:19 Jul, 2019, 15:59 PM IST

BSE
1618.05
Change Change %
-23.45 -1.43%

Updated:19 Jul, 2019, 16:01 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

1620.05 1659.90

52 Wk Range

994.95 1774.95
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

1618.051657.50

52 Wk Range

994.95 1769.00
 

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Edelweiss
-
28-05-2018 Sell 1092.00 1020.00 Target Hit Details
Edelweiss
-
30-01-2018 Sell 1093.00 1020.00 Target Hit Details
Religare
-
29-03-2017 Hold 630.50 600.00 Target Hit Details
Religare
-
28-03-2017 Hold 634.75 600.00 Target Hit Details
HSBC
-
26-12-2016 Hold 785.00 934.00 Target Hit Details

More from Research Reports »

Divis Lab's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 43,122.78
Earning Per Share (EPS TTM) (₹) 50.20
Price To Earnings (P/E) Ratio 32.36
Book Value Per Share (₹) 224.51
Price To Books (P/B) Ratio 7.24
EBIT Margin (%) 31.84
PAT Margin (%) 22.66
ROCE (%) 21.31
PAT Growth (%) -17.44
Total Debt to Equity (D/E) Ratio 0.01

More from Key Fundamentals »

Divis Lab's Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 53.09 53.09 0.00%
Total Non-Current Liabilities 1,769.95 1,418.95 24.74%
Total Current Liabilities 640.49 655.84 -2.34%
Total Liabilities 8,370.09 7,483.70 11.84%
Total Non-Current Assets 3,816.18 3,444.55 10.79%
Currents Investments 1,889.29 1,630.72 15.86%
Cash and Bank 91.48 66.47 37.63%
Total Current Assets Excluding Current Investments 2,664.62 2,408.43 10.64%
Total Assets 8,370.09 7,483.70 11.84%
Profit and Loss:
Gross Sales 3,837.23 4,065.78 -5.62%
Net Sales 3,815.94 4,023.85 -5.17%
PBIDT (Excl OI) 1,251.61 1,438.88 -13.01%
PAT 869.58 1,053.27 -17.44%

More from Financial Summary »

Divis Lab's Shareholding Pattern

's Futures and Options Quotes

Contract
Expiry Date
Type Current price Change Change % Premium / Discount
DIVISLAB
25-07-2019
FUTSTK
1623.50 1.70 0.10% -0.90
DIVISLAB
29-08-2019
FUTSTK
1618.25 1.35 0.08% -6.15
DIVISLAB
26-09-2019
FUTSTK
1646.50 0.00 0.00% 22.10

More from Futures and Options Quotes »

Divis Laboratories Ltd.

Divi's Laboratories is a pharmaceuticals company headquartered in Hyderabad. Besides the manufacture of APIs (Active Pharmaceutical Ingredients) for generics, Divi's Laboratories is engaged in custom synthesis of APIs and Advanced intermediates for discovery compounds for pharma giants, building blocks for peptides/nucleotides, carotenoids, chiral ligands and protected amino-acids, among others. In FY17, Divi's Laboratories registered a net profit of Rs 1,053 crore over revenue of Rs 4,066 crore. As of September 2017, the promoter group of Divi's Laboratories held a 52.07 per cent stake in the company, while the remaining 47.93 per cent was with the public.


Divis Laboratories shares

Divi's Laboratories shares trade with symbol DIVISLAB on stock exchanges NSE and BSE.


History

Divi's Laboratories was founded in 1990 by Dr Murali K Divi.

Background

Established with R&D as its prime fundamental, Divi's Laboratories has expanded its operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Registered office

1-72/23(P)/DIVIS/303, Divi Towers, Cyber Hills, Gachibowli, Hyderabad, Telangana-500032

Post your comments about Divis Lab

Top